SNRPD1 may as an oncogene regulating the tumorigenesis and progression of HCC through regulates the mTOR pathway and autophagy, suggesting that designing new drugs targeting SNRPD1 may provide new insight and methods for the treatment of HCC. This evidence concerns the gene MTOR and hepatocellular carcinoma.